{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:56:21Z","timestamp":1791910581104,"version":"4.3.4"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,3,26]],"date-time":"2018-03-26T00:00:00Z","timestamp":1522022400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"CAPES Foundation","award":["PDSE - 88881.134023\/2016-01"],"award-info":[{"award-number":["PDSE - 88881.134023\/2016-01"]}]},{"name":"NIHR Biomedical Research Council","award":["BRC233\/CM\/SD\/101320"],"award-info":[{"award-number":["BRC233\/CM\/SD\/101320"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drugs Ther"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1007\/s10557-018-6781-2","type":"journal-article","created":{"date-parts":[[2018,3,26]],"date-time":"2018-03-26T04:31:07Z","timestamp":1522038667000},"page":"165-168","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":58,"title":["The Caspase 1 Inhibitor VX-765 Protects the Isolated Rat Heart via the RISK Pathway"],"prefix":"10.1007","volume":"32","author":[{"given":"Helison","family":"Do Carmo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sapna","family":"Arjun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orlando","family":"Petrucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek M","family":"Yellon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean M","family":"Davidson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,26]]},"reference":[{"issue":"6","key":"6781_CR1","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1093\/cvr\/cvx049","volume":"113","author":"DJ Hausenloy","year":"2017","unstructured":"Hausenloy DJ, Garcia-Dorado D, Botker HE, Davidson SM, Downey J, Engel FB, et al. Novel targets and future strategies for acute cardioprotection: position paper of the European Society of Cardiology Working Group on Cellular Biology of the Heart. Cardiovasc Res. 2017;113(6):564\u201385.","journal-title":"Cardiovasc Res"},{"issue":"10","key":"6781_CR2","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1161\/CIRCULATIONAHA.117.029859","volume":"136","author":"DJ Hausenloy","year":"2017","unstructured":"Hausenloy DJ, Yellon DM. Combination therapy to target reperfusion injury after ST-segment-elevation myocardial infarction: a more effective approach to cardioprotection. Circulation. 2017;136(10):904\u20136.","journal-title":"Circulation"},{"issue":"11","key":"6781_CR3","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/nrcardio.2017.102","volume":"14","author":"RA Kloner","year":"2017","unstructured":"Kloner RA, Brown DA, Csete M, Dai W, Downey JM, Gottlieb RA, et al. New and revisited approaches to preserving the reperfused myocardium. Nat Rev Cardiol. 2017;14(11):679\u201393.","journal-title":"Nat Rev Cardiol"},{"issue":"9","key":"6781_CR4","doi-asserted-by":"publisher","first-page":"e107639","DOI":"10.1371\/journal.pone.0107639","volume":"9","author":"W Zhang","year":"2014","unstructured":"Zhang W, Xu X, Kao R, Mele T, Kvietys P, Martin CM, et al. Cardiac fibroblasts contribute to myocardial dysfunction in mice with sepsis: the role of NLRP3 inflammasome activation. PLoS One. 2014;9(9):e107639.","journal-title":"PLoS One"},{"issue":"1","key":"6781_CR5","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1093\/cvr\/cvt091","volume":"99","author":"O Sandanger","year":"2013","unstructured":"Sandanger O, Ranheim T, Vinge LE, Bliksoen M, Alfsnes K, Finsen AV, et al. The NLRP3 inflammasome is up-regulated in cardiac fibroblasts and mediates myocardial ischaemia-reperfusion injury. Cardiovasc Res. 2013;99(1):164\u201374.","journal-title":"Cardiovasc Res"},{"issue":"6","key":"6781_CR6","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1177\/1074248417702890","volume":"22","author":"XM Yang","year":"2017","unstructured":"Yang XM, Downey JM, Cohen MV, Housley NA, Alvarez DF, Audia JP. The highly selective caspase-1 inhibitor VX-765 provides additive protection against myocardial infarction in rat hearts when combined with a platelet inhibitor. J Cardiovasc Pharmacol Ther. 2017;22(6):574\u20138.","journal-title":"J Cardiovasc Pharmacol Ther"},{"issue":"3","key":"6781_CR7","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.biocel.2005.09.017","volume":"38","author":"SM Davidson","year":"2006","unstructured":"Davidson SM, Hausenloy D, Duchen MR, Yellon DM. Signalling via the reperfusion injury signalling kinase (RISK) pathway links closure of the mitochondrial permeability transition pore to cardioprotection. Int J Biochem Cell Biol. 2006;38(3):414\u20139.","journal-title":"Int J Biochem Cell Biol"},{"issue":"2","key":"6781_CR8","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1111\/jcmm.13394","volume":"22","author":"X Rossello","year":"2017","unstructured":"Rossello X, Riquelme JA, Davidson SM, Yellon DM. Role of PI3K in myocardial ischaemic preconditioning: mapping pro-survival cascades at the trigger phase and at reperfusion. J Cell Mol Med. 2017;22(2):926\u201335.","journal-title":"J Cell Mol Med"},{"issue":"6","key":"6781_CR9","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s00395-017-0657-7","volume":"112","author":"X Rossello","year":"2017","unstructured":"Rossello X, Riquelme JA, He Z, Taferner S, Vanhaesebroeck B, Davidson SM, et al. The role of PI3Kalpha isoform in cardioprotection. Basic Res Cardiol. 2017;112(6):66.","journal-title":"Basic Res Cardiol"},{"issue":"2","key":"6781_CR10","doi-asserted-by":"publisher","first-page":"H971","DOI":"10.1152\/ajpheart.00374.2004","volume":"288","author":"DJ Hausenloy","year":"2005","unstructured":"Hausenloy DJ, Tsang A, Mocanu MM, Yellon DM. Ischemic preconditioning protects by activating prosurvival kinases at reperfusion. Am J Physiol Heart Circ Physiol. 2005;288(2):H971\u20136.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"5","key":"6781_CR11","first-page":"629","volume":"3","author":"EK Iliodromitis","year":"2007","unstructured":"Iliodromitis EK, Lazou A, Kremastinos DT. Ischemic preconditioning: protection against myocardial necrosis and apoptosis. Vasc Health Risk Manag. 2007;3(5):629\u201337.","journal-title":"Vasc Health Risk Manag"}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10557-018-6781-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-018-6781-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-018-6781-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T09:11:44Z","timestamp":1719911504000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10557-018-6781-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,26]]},"references-count":11,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["6781"],"URL":"https:\/\/doi.org\/10.1007\/s10557-018-6781-2","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"value":"0920-3206","type":"print"},{"value":"1573-7241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,26]]},"assertion":[{"value":"26 March 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"All applicable international, national, and\/or institutional guidelines for the care and use of animals were followed.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}